Anzeige
Mehr »
Login
Sonntag, 14.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Spezial: Montag letzte Chance vor großer Verkündung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
28.12.23Eli Lilly concludes POINT Biopharma acquisition for $1.4bn
27.12.23Innovent and SanegeneBio partner for hypertension drug development
26.12.23FDA grants priority review for Daiichi Sankyo-Merck's lung cancer therapy
22.12.23SELLAS receives orphan drug designation for PTCL therapy
21.12.23Calliditas receives approval for Nefecon to treat IgAN
20.12.23LimmaTech, AbVacc sign licensing agreement for S. aureus vaccine candidate
19.12.23Allay grants acute pain management drug license to Japan's Maruishi Pharmaceutical
18.12.23Arcutis Biotherapeutics receives FDA approval for ZORYVE to treat seborrheic dermatitis
15.12.23Merck gets FDA approval for WELIREG to treat advanced renal cell carcinoma
14.12.23Aldevron signs agreement to acquire license to Codex HiCap RNA Polymerase
13.12.23Almirall signs alliance with etherna for new mRNA-based therapies
12.12.23Lavipharm signs agreement with Sanofi to acquire Flagyl
11.12.23Rigel, MD Anderson partner to expand REZLIDHIA assessment in AML
08.12.23USFDA accepts NextPoint Therapeutics's IND for NPX887
07.12.23Voyager Therapeutics selects lead development candidate for SOD1 ALS gene therapy programme
06.12.23Novartis receives FDA approval for Fabhalta to treat PNH in adults
05.12.23China NMPA accepts Everest Medicines' IND application for zetomipzomib
04.12.23AbbVie agrees to acquire ImmunoGen for around $10.1bn
01.12.23Phenomic AI, Astellas partner to develop solid tumour cell therapies
30.11.23US FDA accepts Karuna's NDA for schizophrenia therapy
29.11.23Evommune, Accutar to discover drug candidates for chronic inflammatory diseases
28.11.23Sernova secures ODD and RPDD for Haemophilia A programme
27.11.23Mesoblast files applications with US FDA for HLHS therapy
24.11.23Boehringer Ingelheim announces acquisition of T3 Pharmaceuticals
23.11.23US FDA approves Valneva's vaccine against chikungunya virus